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Diminished parathyroid 1 ,25(OH)2D3 receptors in experimental
uremia. In Sprague Dawley rats, six days after subtotal nephrectomy,
serum 1,25(OH)2D3 concentration was diminished (59.8 17.5 pg/mI
vs. 121 48; P < 0.01). Despite low circulating l,25(OH)2D3 levels,
maximal specific binding capacity for I ,25(OH)2D1 in parathyroid
glands was diminished (Nmax 87.5 fmol/mg protein and 3.52 fmol/mg
DNA vs. 143 fmol/mg protein and 4.75 fmol/mg DNA, respectively).
There was no change of K0, apparent molecular size (sucrose density
gradient) and DNA binding affinity (DNA cellulose chromatography)
pointing to intactness of the receptor. Since I ,25(OH)2D3 is a potent
negative feedback signal for parathyroids, the data are potentially
relevant for the genesis of secondary renal hyperparathyroidism.
Secondary hyperparathyroidism of renal failure continues to
be a serious problem in patients with renal failure, but its
pathogenesis is poorly understood. In the past, it has been
thought that oversecretion of parathyroid hormone (PTH) was
triggered by hypocalcemia [II. More recently, it has been
appreciated that l,25(OH)2D3, the bioactive metabolite of vita-
min D3, is an important modulator of PTH secretion [2, 31 and
biosynthesis [4, 5]. Modest doses of l,25(OH)2D3, such as 100
pmol iv,, suppress mRNA for preproPTH by 80% with no
increase in serum calcium [6]. Consequently, low circulating
levels of 1 ,25(OH)2D3 may be important in the genesis of renal
secondary hyperparathyroidisni. Since such hyperparathyroid-
ism does occur, however, even in the presence of normal
1,25(OH)2D3 levels, such as in incipient renal failure [71, we
evaluated whether phenotypic expression of receptors for
1 ,25(OH)2D3 on parathyroid glands was abnormal in experimen-
tal renal failure.
Methods
Animals
Male 170 g Sprague Dawley (SD) rats (Ivanovas Co., Kis-
slegg/Allgau) were either sham operated (decapsulation of kid-
ney) or subjected to subtotal nephrectomy under NembutaI'
anaesthesia.
Following surgery, the animals were kept in single cages and
the same amount of food was given to controls and experimen-
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tal animals (pair feeding). Animals were kept on Altromin diet C
1000 with 600 U vitamin D3Ikg, 0.95% Ca, 0.65% Pi (wt!vol)
(Altromin Co., Lage/Lippe). After six days and 16 days, respec-
tively parathyroid glands were removed using rnicrosurgical
techniques and immediately placed in liquid nitrogen. In a
separate series parathyroid glands were weighed on a Mettler
H54 AR balance (Mettler Co., Ffm.) or used for micromorph-
ometry.
Measurements
Serum creatinine and urea were measured using Autoana-
lyzer techniques. 1,25(OH)2D3 was measured after Extrelut
extraction using a radioimmunoassay [8]. Protein was measured
after Lowry et al [9] and DNA after Burton [101.
Chemicals
1,25-dihydroxy [26,27-methyl-3H1 cholecalciferol (158 Ci!
mmol) from Amersham/Buchler Co. (Braunschweig). Radio-
chemical purity was by HPLC at 93 to 98% with no other
vitamin D metabolites demonstrated. Radioinert, chromato-
graphically pure l,25(OH)2D3 was from Hoffman—La Roche
AG, Grenzach. Bovine serum albumin [14C] methylated (20
MCi/mg protein); ovalbumin ['4C1 methylated (20 Ci1mg pro-
tein), y-globulin ['4C] methylated (20 Ci!mg protein) were from
NEN (Dreieichenhain). Hydroxylapatite, dithiothreitol, Triton
X-l00, Na-molybdate were from Sigma (MUnchen).
Micromorphometric analysis
One parathyroid gland per animal was randomly chosen and
carefully excised for morphometric investigations. All speci-
mens were fixed for 24 hours in ice cold 0.1 M phosphate buffer
containing 1.5% paraformaldehyde and 1.5% glutaraldehyde
and afterwards in 1% OsO4 for 30 minutes at room temperature,
dehydrated in ethanol and embedded in EPON—ARALDITE.
Semithin sections (1 m) were stained with methylene blue and
basic fuchsin [11] and examined by light microscopy using oil
immersion and phase contrast.
The volume densities (volume per unit tissue volume) of
epithelial cells (Vv(e)) and interstitial tissue (Vv(i)), and the
volume ratio of epithelial cell nuclei and epithelial cells [nuclear
volume per unit cell volume (Vv(n)1 were estimated using the
point counting procedure [12]. Two random sections of each
gland were selected for analysis. The test areas were obtained
by random systematic subsampling. Eight tests areas (58,000
350
Parathyroid I,25(OH)2D3 receptors n uremia 351
Table 1. Serum chemistry
Controls
N=50
Urem
N=
ia
50
Serum creatinine SM/liter 27.2 7.2 215 120
Serum urea mM/liter 6.17 2.17 68.7 14
1,25 (OH)2D3 pg/mI 121 48 59.8 17.5
All differences P < 0.01, Wilcoxon test for random samples.
m2) per gland were analyzed with a Zeiss eyepiece containing
100 test points (Zeiss, Oberkochen, FRG). Reference volume
was the total volume of the parathyroid glands.
Analytical techniques
Nuclear preparation. Methods as described before [13, 14].
In brief, pooled parathyroids of 20 animals were homogenized
in 4 volumes (wt/vol) of KCI-free buffer (TED) (10 mM Tris
HCI, 1.5 mrvi EDTA, 1 mivi DTT, 10 m sodium molybdate, pH
7.4; 4°C) using a high speed Polytron homogenizer (10 bursts
per 10 sec) at the temperature of melting ice. Homogenate was
centrifuged (5000 g; 10 mm; 4°C) to yield the nuclear pellet. A
crude chromatin fraction was prepared by resuspending the
pellet three times in the above buffer with 0.5% Triton X-100
(pH 7.4) followed by centrifugation (10,000 g; 10 mm). The
resulting crude chromatin pellet was then extracted with 0.4 M
KC1-TED for 45 minutes with frequent mixing. Chromatin
extract was centrifuged (5,000 g/10 mm) and the resulting super-
natant subsequently centrifuged at 100,000 g for one hour at
4°C.
Saturation analysis according to Scatchard 115]. Aliquots
(0.1 ml) of nuclear extract (0.3 mg protein/mi) were incubated
with varying concentrations (0.1 to 10 nmol) of [3H]l,25
(OH)2D3 for three hours in the absence (total binding) or
presence (non-specific binding) of 100-fold molar excess of
unlabeled 1,25(OH)2D3, all for 16 hours at 4°C. Bound [3H]l,25
(OH)2D3 was determined using the hydroxylapatite assay as
described before [13, 141.
Recovery of receptor from tissue of uremic animals. To
explore whether receptor was lost from uremic tissue because
of proteolysis, we performed a mixing experiment to determine
recovery after addition of TED homogenate of sham—operated
control animals to TED homogenate of uremic animals. Be-
cause of limited availability of parathyroid tissue, these studies
were carried out with epidermis in which we previously showed
presence of l,25(OH)2D3 receptors [14]. Incubations to measure
total and non-specific binding were carried out at 3 nrvi [3H1
1 ,25(OH)2D3.
Sucrose density of gradient analysis. In brief, linear 5 to 20%
sucrose density gradient in KTEDMo-buffer (4 ml) was made
using a self—designed gradient former. Nuclear samples (0.2 ml)
were incubated with I flM [3H]l,25(OH)2D3 alone or after
addition of 100-fold molar excess of 1,25(OFI)2D3. They were
then carefully layered on top of preequilibrated (2 hr, 4°C)
gradients and centrifuged (255,000 g; 21 hr; 4°C, SW 60 rotor
Beckman Instruments Co., Fullerton, California, USA).
Seven—drop fractions were collected. The sedimentation rate
(in Svedberg units, S) for proteins was calculated using [14C]
labeled ovalbumin (3.7 S) or gammaglobulin (7.3 S).
Table 2. Parathyroid weight and stereological measurements
Control (N) Uremia (N)
Parathyroid weight g 160 72 (50) 303 120 (50)"
Protein/DNA ratio 3.20 3.08°
(g protein/pig DNA)
Volumetric density %
of epithelial cells, V(e) 93.0 3.2 (12) 94.9 2.8 (16) N.S.
of interstitial tissue, 7.0 3.2 5.1 2.8
V (i)
Nuclear volume per
unit cell volume %
of epithelial cells V (n) 21.2 5.7 18.8 4.7
a Number of animals examinedb P <0.01; Wilcoxon's test for random samples
Tissue poo1 of 30 glands, mean of duplicate measurements
Binding of I,25(OH)2D3 receptors to DNA cellulose. DNA
cellulose polymerized calf thymus DNA (type I, Sigma') and
Whatman CF-li cellulose [16]. Each column, 1.5 X 6cm, was
equilibrated in TED for 16 hours at 4°C prior to use and run at
a flow rate of 5 ml/hr/cm2. Samples were loaded onto the
columns, washed with three volumes of TED and eluted in 10
volumes with a linear gradient from 0.1 M to 0.8 M KC1 in TED.
Nuclear extracts (0.6 ml/i .8 mg protein) of cell fractions were
incubated for two hours at 4°C with 1 nM [3H]l,25(OH)2D3 (±
100-fold molar excess of radioinert 1 ,25(OH)2D3) prior to chro-
matography on DNA cellulose.
Statistics
All data are given as arithmetic means SD. Wilcoxon's test or
Student's t-test for unpaired data were employed as appropriate.
Results
Serum chemistry
Six days after subtotal nephrectomy, plasma 1 ,25(OH)2D3
concentration was decreased and serum creatinine and serum
urea concentrations significantly increased (Table 1).
Parathyroid weight and morphology
Six days after subtotal nephrectomy, parathyroid gland
weight was significantly increased with no change of protein/
DNA ratio in pooled tissue (Table 2).
Stereological measurements showed no difference of the
partitioning between epithelial cells and interstitial tissues.
Because of the presumed nuclear location of the receptor it is of
note that the nuclear volume represented an unchanged propor-
tion of total cell volume in the uremic animals.
Scatchard analysis
The binding isotherms of [3H] 1 ,25(OH)2D3 for nuclear frac-
tions of control and uremic animals, shown in Figure 1, give one
representative example of three identical consecutive experi-
ments. The difference of Nmax was similar when expressed per
mg protein (Fig. 1) and per mg DNA (2.52 fmollmg DNA in
uremia vs. 4.75 in controls). KD was similar in uremic animals
and in controls (insert, Fig. 1). In a pilot experiment, parathy-
roid glands of animals with uremia of 16 days duration showed
a similar decrease of Nmax (86 0.8 fmol/mg protein in uremic
animals vs. 121 2.8 fmol/mg in controls; three replicate
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measurements of one tissue pooi from 15 animals). Recovery of
I ,25(OH)D3 receptor in the nuclear fraction after mixing of
epidermal tissue homogenates of control and uremic animals
was 92.3%.
Sucrose density gradient analysis and DNA affinity
chromatography
To evaluate whether receptors were damaged by uremia,
such as by proteolysis, we evaluated the binding kinetics which
suggested a single class of noninteracting receptors with un-
changed K in uremic animals. We also examined apparent
molecular size on sucrose density gradient. In both uremic
animals and controls, [3H]1,25(OH)2D3 was similarly bound by
a 3.5 S macromolecule (defined by migration relative to ['4C]-
ovalbumin (3.7 S) and y-globulin (7.3 S). Binding was specific,
Fig. 1. A. Saturation analysis (Scatchard) with [3H]
1,25(OH)2D3 in parathyroids (pool of 40 glands each) of
control and uremic animals, respectively, (O—O) total
binding (upper line); (• •) spec j/lc binding; (O—O)
+100 X non-specific binding (lower line). Note reduction of Nmax
1,25 (OH)2D3 with no change of K0 in uremic animals (insert). B.
Sucrose density gradient analysis (5 to 20%) with
[3H] 1 ,25(OH)2D3 in nuclear extract of pooled parathyroid
To glands of control and uremic animals (• •)incubation with 1 nmol [3H] 1 ,25(OH)2D3; (0 0)
incubation with 1 nmol [3H1 I ,25(OH)2D3 in presence of
100-fold molar excess of radioinert I ,25(OH)2D3.
that is, it was reversed by 100-fold molar excess of radioinert
1 ,25(OH)7D3. Finally, DNA affinity chromatography on DNA
cellulose showed unchanged binding of the [3HJ1 ,25(OH)2D3
prelabeled holoreceptor, which eluted as a well defined peak at
0.22 M KCI in both uremic animals and controls. Of specific
binding, 86.9% was recovered in the fractions bracketing 0.09 to
0.35 M KC1 in controls and 81.7% in uremic animals. A similar
proportion of specific binding (3.6% in controls, 4.5% in uremic
animals) appeared in the void volume.
Discussion
Parathyroid glands have previously been shown to bind
specifically 1 ,25(OH)2D3 using autoradiographic [171 and
radioligand binding techniques [18]. 1,25(OH)2D3 is known to
affect parathyroid gland ultrastructure [21, circulating PTH
levels [3] and mRNA for pre-pro-PTH [4, 61, thus providing an
Nmax 142.8 fmol/m prot,
K0=1.47x10 M(r=0.96)
Nr,,ax=87.5 fmol/m prot.
K0=1.51x101 M
(r=0.97)
Free 13H1-1,25 (OH)2D3, flM
Control
Glob (7.3S) Ov (3.7S)44
mM
13H1-1,25 (OH)203
+ 100x
1,25 (OH)2D3
.lflM
13H1-1,25 (OH)2D3
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important negative feedback signal to the gland. The present
study demonstrates that uremia of six days or 16 days duration
respectively diminishes maximal specific binding capacity of
the parathyroids for 1 ,25(OH)2D3. Because of increased para-
thyroid weight, binding was calculated both as a function of
protein and of DNA content. With both frames of reference, the
relative difference was similar. Stereological analysis of para-
thyroid tissue showed a harmonious increase of all tissue
components with unchanged nucleus/epithelial cell ratio.
Uremia is a state of catabolism with proteolysis in numerous
tissues [19]. To exclude receptor damage we evaluated KD,
molecular size and binding affinity for DNA, all of which were
unchanged. Furthermore, in a mixing experiment, recovery of
receptor from tissue homogenate of control animals added to
homogenate of uremic animals was almost 100%. Because the
pure receptor molecule is not available, we could not formally
examine potential receptor loss during preparation of the
euchromatin preparation; consequently, differential loss during
this step cannot be excluded as a cause for the difference
between uremic animals and control animals.
The mechanism by which specific 1 ,25(OH)2D3 binding is
diminished remains undefined. Circulating 1,25(OH)2D3 levels
were decreased; it is therefore unlikely that the finding reflects
changes in receptor occupancy. Low 1 ,25(OH)2D3 levels also
argue against homologous (down) regulation of the receptor.
The parathyroids undergo rapid proliferation as indicated by
increased weight; we cannot exclude that non-receptor bearing
cells appear in the proliferating gland. However, in proliferating
cells of various tissues, 1 ,25(OH)2D3 receptor increase, such as
in endothelial cells [20]. It is therefore unlikely that the finding
reflects an artefact of hyperplasia. In intestinal mucosa we
found no change of 1 ,25(OH)2D3 receptors with administration
of high doses of 1 ,34bPTH (2 x 5 U/d i.p. for 5 days) and NH4C1
(2 x 2.5 mM/day by gavage for 4 days, data not given). Because
of limited availability of tissue, parathyroids could not be
examined in parallel, but this observation argues against the
possibility that the receptor changes reflect PTH excess or
metabolic acidosis.
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